Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Oct;19(7):2073-2093.
doi: 10.1007/s12015-023-10577-3. Epub 2023 Jul 13.

Current Progress in Stem Cell Therapy for Male Infertility

Affiliations
Review

Current Progress in Stem Cell Therapy for Male Infertility

Rajendra Falah Adriansyah et al. Stem Cell Rev Rep. 2023 Oct.

Abstract

Infertility has become one of the most common issues worldwide, which has negatively affected society and infertile couples. Meanwhile, male infertility is responsible for about 50% of infertility. Accordingly, a great number of researchers have focused on its treatment during the last few years; however, current therapies such as assisted reproductive technology (ART) are not effective enough in treating male infertility. Because of their self-renewal and differentiation capabilities and unlimited sources, stem cells have recently raised great hope in the treatment of reproductive system disorders. Stem cells are undifferentiated cells that can induce different numbers of specific cells, such as male and female gametes, demonstrating their potential application in the treatment of infertility. The present review aimed at identifying the causes and potential factors that influence male fertility. Besides, we highlighted the recent studies that investigated the efficiency of stem cells such as spermatogonial stem cells (SSCs), embryonic stem cells (ESCs), very small embryonic-like stem cells (VSELs), induced pluripotent stem cells (iPSCs), and mesenchymal stem cells (MSCs) in the treatment of various types of male infertility.

Keywords: Andrology; Azoospermia; Male infertility; Reproductive health; Stem cell transplantation; Stromal cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Vander Borght, M., & Wyns, C. (2018). Fertility and infertility: Definition and epidemiology. Clinical Biochemistry, 62, 2–10. https://doi.org/10.1016/j.clinbiochem.2018.03.012 - DOI - PubMed
    1. Panner Selvam, M. K., Ambar, R. F., Agarwal, A., & Henkel, R. (2021). Etiologies of sperm DNA damage and its impact on male infertility. Andrologia, 53(1), e13706. https://doi.org/10.1111/and.13706 - DOI - PubMed
    1. Agarwal, A., Parekh, N., Panner Selvam, M. K., Henkel, R., Shah, R., Homa, S. T., Ramasamy, R., Ko, E., Tremellen, K., Esteves, S., et al. (2019). Male oxidative stress infertility (MOSI): Proposed terminology and clinical practice guidelines for management of idiopathic male infertility. World Journal of Men’s Health, 37(3), 296–312. https://doi.org/10.5534/wjmh.190055 - DOI - PubMed
    1. Ring, J. D., Lwin, A. A., & Köhler, T. S. (2016). Current medical management of endocrine-related male infertility. Asian Journal of Andrology, 18(3), 357–363. https://doi.org/10.4103/1008-682x.179252 - DOI - PubMed - PMC
    1. Turner, K. A., Rambhatla, A., Schon, S., Agarwal, A., Krawetz, S. A., Dupree, J. M., & Avidor-Reiss, T. (2020). Male infertility is a women’s Health issue-research and clinical evaluation of male infertility is needed. Cells, 9(4), https://doi.org/10.3390/cells9040990

LinkOut - more resources